Biomarkers Market: How Is the Cardiovascular Biomarker Segment...

added blog Wellness

2026-06-05 09:56:01 -

Biomarkers Market: How Is the Cardiovascular Biomarker Segment Creating the Fastest Commercial Growth Adjacent to Oncology?

Cardiovascular biomarker's commercial growth acceleration — the commercial convergence of high-sensitivity cardiac troponin assays enabling myocardial infarction rule-out in three hours rather than six, natriuretic peptide biomarkers BNP and NT-proBNP guiding heart failure diagnosis and treatment monitoring in primary care settings, novel biomarkers of cardiac injury and fibrosis...

0 Comments 0 Shares 324 Views 0 Reviews